MRNA Moderna Inc

USD 176.35 2.05 (+1.18%)
At close: 04:00PM EST
Icon

Moderna Inc Stock Analysis and Price Target COMMON STOCK | Biotechnology | NSD

stockTargetAdvisor

Hold

Average User
Rating
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis

USD 174.30

-1.76 (-1.00)%

USD 67.64B

5.60M

USD 164.96(-5.36%)

USD 231.13 (+32.60%)

Icon

MRNA

Moderna Inc (USD)
COMMON STOCK | NSD
USD 176.35
2.05 (+1.18%)
At close: 04:00PM EST
stockTargetAdvisor

Hold

Average User
Rating
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis

USD 67.64B

USD 231.13 (+32.60%)

USD 174.30

Moderna Inc Stock Forecast

USD 164.96
(-5.36%)

Based on the Moderna Inc stock forecasts from 12 analysts, the average analyst target price for Moderna Inc is USD 164.96 over the next 12 months. Moderna Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Moderna Inc is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Moderna Inc’s stock price was USD 174.30. Moderna Inc’s stock price has changed by -9.72% over the past week, -2.96% over the past month and +0.90% over the last year.

No recent analyst target price found for Moderna Inc
No recent average analyst rating found for Moderna Inc

Company Overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and in...Read More

https://www.modernatx.com

200 Technology Square, Cambridge, MA, United States, 02139

3,700

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

  • 1.71

  • USD 217.25

  • 2.00

  • USD 115.03

  • 14,042,188

  • USD 155.71

  • 14,041,300

  • USD 186.15

  • 9.68%

  • 4.96%

  • 67.89%

  • N/A

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Security Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Moderna Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -5.83 (-1.80%) USD82.14B 25.24 16.84
REGN
Regeneron Pharmaceuticals Inc -0.47 (-0.06%) USD80.20B 15.52 12.07
ALXN
Alexion Pharmaceuticals Inc 0.00 (0.00%) USD40.34B 59.23 42.56
BNTX
BioNTech SE -0.36 (-0.25%) USD34.86B 3.27 2.14
ALNY
Alnylam Pharmaceuticals Inc -1.49 (-0.66%) USD27.73B N/A -29.42
BGNE
BeiGene Ltd -1.72 (-0.67%) USD26.95B N/A -9.58
SGEN
Seagen Inc -0.45 (-0.32%) USD25.90B 55.02 -38.86
GMAB
Genmab AS -0.03 (-0.08%) USD25.68B 30.85 3.59
BMRN
Biomarin Pharmaceutical Inc +1.36 (+1.18%) USD21.32B 266.74 90.91
ARGX
argenx NV ADR -2.52 (-0.66%) USD21.13B N/A -21.25

ETFs Containing MRNA

Symbol Name Weight Mer Price(Change) Market Cap
BTEC:SW
iShares Nasdaq US Biotech.. 7.43 % 0.00 % -0.01 (-0.11%) USD0.47B
2B70:XETRA
iShares Nasdaq US Biotech.. 7.43 % 0.35 % -0.10 (-1.69%) USD0.46B
2B70:F
iShares IV Public Limited.. 7.43 % 0.35 % +0.04 (+0.63%) USD0.46B
MSGR
Direxion mRNA ETF 7.08 % 0.65 % +0.18 (+1.16%) USD4.43M
IBBQ
Invesco Nasdaq Biotechnol.. 6.74 % 0.19 % -0.01 (-0.05%) USD0.02B
ZGEN:CA
BMO MSCI Genomic Innovati.. 6.72 % 0.40 % +0.01 (+0.05%) USD4.47M
BTEC:LSE
iShares Nasdaq US Biotech.. 6.40 % 0.35 % -0.07 (-1.14%) USD0.47B
BTEE:LSE
iShares Nasdaq US Biotech.. 6.40 % 0.35 % -0.07 (-1.10%) USD0.04B
BTEK:LSE
iShares Nasdaq US Biotech.. 6.40 % 0.35 % -0.05 (-1.03%) USD0.47B
BBH
VanEck Biotech ETF 5.82 % 0.35 % +0.10 (+0.06%) USD0.54B
IBB
iShares Biotechnology ETF 5.73 % 0.44 % +0.16 (+0.12%) USD8.94B
BIB
ProShares Ultra Nasdaq Bi.. 5.25 % 0.95 % -0.29 (-0.47%) USD0.11B
BUL
Pacer US Cash Cows Growth.. 4.82 % 0.60 % -0.37 (-1.00%) USD0.04B
ZINN:CA
BMO MSCI Innovation Index.. 4.43 % 0.40 % +0.72 (+3.17%) USD0.02B
GERM
ETFMG Treatments Testing .. 4.13 % 0.68 % -0.10 (-0.40%) USD0.02B
IDNA
iShares Genomics Immunolo.. 4.08 % 0.47 % +0.27 (+1.00%) USD0.17B
TECB
iShares U.S. Tech Breakth.. 3.85 % 0.40 % +0.79 (+2.58%) USD0.34B
LS:CA
Middlefield Healthcare & .. 3.47 % 0.85 % 0.00 (0.00%) USD0.09B
MHCD:CA
Middlefield Healthcare Di.. 3.47 % 0.00 % +0.10 (+0.91%) N/A
SXQG
6 Meridian Quality Growth.. 3.20 % 1.00 % +0.36 (+1.67%) USD0.03B
BBIG:CA
Horizons Global BBIG Tech.. 3.14 % 0.45 % 0.00 (0.00%) USD3.31M
FHH-F:CA
First Trust AlphaDEX U.S... 3.09 % 0.79 % 0.00 (0.00%) USD0.02B
NZRO
Strategy Shares Halt Clim.. 2.20 % 0.95 % +0.18 (+0.82%) USD1.09M
FXH
First Trust Health Care A.. 2.18 % 0.61 % +1.28 (+1.14%) USD1.66B
ZUH:CA
BMO Equal Weight US Healt.. 2.07 % 0.39 % +1.19 (+1.66%) USD0.43B
SPGP
Invesco S&P 500 GARP ETF 2.04 % 0.33 % +1.48 (+1.65%) USD2.34B
HEAL:LSE
iShares Healthcare Innova.. 1.70 % 0.40 % +0.02 (+0.28%) USD1.41B
DRDR:LSE
iShares Healthcare Innova.. 1.70 % 0.40 % +2.25 (+0.36%) USD1.42B
MWD:CA
Mackenzie Maximum Diversi.. 1.68 % 0.55 % +0.05 (+0.19%) USD0.38B
MUS:CA
Mackenzie Maximum Diversi.. 1.65 % 0.50 % +0.14 (+0.43%) USD0.15B
QQEQ:CA
Invesco NASDAQ 100 Equal .. 1.15 % 0.25 % 0.00 (0.00%) USD5.60M
FTGU:XETRA
First Trust US Large Cap .. 0.75 % 0.75 % -0.02 (-0.03%) USD0.10B
FTGU:F
First Trust Global Funds .. 0.75 % 0.75 % +0.26 (+0.42%) USD0.10B
FAD
First Trust Multi Cap Gro.. 0.73 % 0.65 % +1.30 (+1.29%) USD0.17B
IUSS
Invesco RAFI Strategic US.. 0.31 % 0.23 % +0.65 (+1.77%) USD0.10B
QBTL:CA
AGFiQ US Market Neutral A.. 0.21 % 0.55 % -0.43 (-2.26%) USD0.37B
FLAG
First Light Acquisition G.. 0.00 % 1.44 % +0.01 (+0.10%) USD0.10B
ZHU:CA
BMO Equal Weight US Healt.. 0.00 % 0.39 % 0.00 (0.00%) USD0.05B
FHH:CA
First Trust AlphaDEX US H.. 0.00 % 0.77 % 0.00 (0.00%) USD0.02B
HWF:CA
Middlefield Healthcare & .. 0.00 % 0.85 % -0.03 (-0.24%) USD0.05B

Frequently Asked Questions About MRNA Stock

Based on ratings from 12 analysts Moderna Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 4 buy, 6 sell and 11 hold ratings.

Unfortunately we do not have enough data on MRNA's stock to indicate if its a good dividend stock.

Based on targets from 12 analysts, the average taret price for MRNA is USD 164.96 over the next 12 months. The maximum analyst target price is USD 296 while the minimum anlayst target price is USD 74.

MRNA stock's Price/Earning ratio is 6.64. Our analysis grades MRNA stock's Price / Earning ratio at F. This means that MRNA stock's Price/Earning ratio is above 51% of the stocks in the Biotechnology sector in the NSD exchange. Based on this MRNA may be a overvalued for its sector.

The last closing price of MRNA's stock was USD 174.30.

The most recent market capitalization for MRNA is USD 67.64B.

Based on targets from 12 analysts, the average taret price for MRNA is projected at USD 164.96 over the next 12 months. This means that MRNA's stock price may go down by -5.36% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...